-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Equal-Weight on West Pharmaceutical Servs, Raises Price Target to $275

Benzinga·10/02/2025 15:08:24
Listen to the news
Barclays analyst Luke Sergott maintains West Pharmaceutical Servs (NYSE:WST) with a Equal-Weight and raises the price target from $260 to $275.